Crossmark

Design, Synthesis, and Anticancer Evaluation of N-(4-{5-[4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenyl]-4-(2,3,4-trimethoxyphenyl)-1,3-thiazol-2-yl}phenyl)benzamides

Crossref DOI link: https://doi.org/10.1134/S1070428021040187

Published Online: 2021-05-24

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ravinaik, B.

Rao, M. V. B.

Rao, P. T. S. R. K. P.

Ramachandran, D.

Reddy, D. R. S.
License Information

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2021-04-01
More Information

Article History

Received: 5 October 2020

Revised: 21 October 2020

Accepted: 24 October 2020

First Online: 24 May 2021

CONFLICT OF INTEREST

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below